MLS-101
Mineralys Therapeutics
[]
$mlys mineralys therapeutics presents positive lorundrostat results from the phase 2 target-htn trial at acc.23/wcc 
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i